DDAB liposomes find applications in various research areas including drug delivery, gene therapy, vaccine development, and nanomedicine. Researchers utilize these versatile lipid-based carriers to deliver therapeutic agents or genetic materials with improved specificity and efficacy, contributing to advancements in biomedical science.
The optimal concentration of DDAB liposomes depends on the specific experimental setup and the intended application. Researchers typically conduct dose-response studies to determine the appropriate concentration range that achieves desired effects while minimizing potential cytotoxicity.
Several techniques can be employed to characterize DDAB liposomes, including dynamic light scattering (DLS) for size measurement and zeta potential analysis for surface charge determination. Additionally, stability studies involving storage conditions and serum stability assays can provide insights into liposomal behavior over time.
Various methods exist for loading therapeutic cargoes into DDAB liposomes, including passive encapsulation during liposome formation, active loading techniques such as pH gradient or transmembrane ammonium sulfate gradients, and post-insertion methods where preformed liposomes are incubated with the payload.
Optimization of DDAB liposome formulation involves adjusting parameters such as lipid composition, drug-to-lipid ratio, and preparation methods to achieve desired characteristics such as size, stability, and drug release kinetics. Systematic screening and characterization are essential for identifying the optimal formulation.
Cellular uptake of lipoplexes in MCF-7 and HeLa cells
The research provided focuses on the development and application of cationic liposomes formed from mixtures of lecithin and dihexadecyldimethylammonium bromide (DDAB) for the purpose of efficient gene delivery. This study underscores the effectiveness of spontaneously formed cationic vesicles in transfecting plasmid DNA (pDNA) and siRNA into cells, showcasing a novel method for gene therapy. The experimental results reveal that by adjusting the DDAB to phospholipid ratio within these vesicles, their average size can be controlled within the range of 150-300 nm, with a ζ potential of +40 mV, indicative of their cationic nature. The ability of these vesicles to bind and form complexes with pDNA, referred to as lipoplexes, is thoroughly demonstrated through a variety of assays, including ζ potential measurement, isothermal titration calorimetry, and DNase I digestion assay, among others. A particularly significant finding is the binding enthalpy between pDNA and cationic liposome, calculated as -5.7 (±0.8) kJ/mol, emphasizing the favorable energetics of this interaction. Cellular uptake studies further confirm the vesicles' capability to efficiently deliver genetic material into MCF-7 and HeLa cells, with fluorescence microscopy showcasing successful transfection. Additionally, the study elaborates on the potential of these cationic vesicles in delivering siRNA for gene silencing, marking a significant step forward in the utilization of DDAB liposomes for gene delivery applications. This research holds profound implications for the field of gene therapy, presenting a scalable and effective method for the delivery of therapeutic genes and RNA into cells.
Shelar, S. B., Dey, A., et al. Spontaneous Formation of cationic vesicles in aqueous DDAB-Lecithin mixtures for efficient plasmid DNA complexation and gene transfection. ACS Applied Bio Materials. 2021, 4(8): 6005-6015.
Click the button below to contact us or submit your feedback about this product.
Online Inquiry